The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBraveheart Inv Regulatory News (BRH)

Share Price Information for Braveheart Inv (BRH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.00
Bid: 4.00
Ask: 6.00
Change: 0.00 (0.00%)
Spread: 2.00 (50.00%)
Open: 5.00
High: 5.00
Low: 5.00
Prev. Close: 5.00
BRH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

26 Apr 2018 07:00

RNS Number : 1371M
Braveheart Investment Group plc
26 April 2018
 

 

Prior to publication, the information contained within this announcement was deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR"). With the publication of this announcement, this information is now considered to be in the public domain.

26 April 2018

Braveheart Investment Group plc

("Braveheart" or "the Company")

Trading Update

 

Braveheart Investment Group plc (AIM: BRH), the fund management and strategic investor group, is pleased to give the following update on trading ahead of its final results for the year ended 31 March 2018, which will be released on 19 June 2018.

 

During the course of the year the Board continued to be closely involved at the operational level with our three strategic investments which have made further good progress, and in fund management our businesses have met their revenue targets.

 

As a result and reflecting the good progress achieved during the financial year, the Company is pleased to report that following a revaluation of all the Company's investments by an externally commissioned valuer, the Directors expect that, subject to the review of the auditors, the Company will be able to report a substantial increase in the value of its investment portfolio, primarily in its investments in Paraytec Limited and Kirkstall Limited. In addition, trading at Viking Fund Managers for the year ended 31 March 2018 is expected to show a slight improvement on the last financial year.

 

As a result, the Directors expect to report, subject to audit, a substantially increased profit after tax for the year ended 31 March 2018 compared to the prior year.

 

 

 

 

Further information:

Braveheart Investment Group plc

Trevor Brown, Chief Executive Tel: +44 1738 587555

Allenby Capital Limited (Nominated Adviser and Broker to Braveheart)

David Worlidge / Nicholas Chambers Tel: +44 20 3328 5656

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFEESIIEFIT
Date   Source Headline
5th Nov 20204:41 pmRNSSecond Price Monitoring Extn
5th Nov 20204:36 pmRNSPrice Monitoring Extension
4th Nov 20208:52 amRNSExercise of Warrants and Issue of Equity
3rd Nov 202011:06 amRNSSecond Price Monitoring Extn
3rd Nov 202011:00 amRNSPrice Monitoring Extension
2nd Nov 20202:06 pmRNSSecond Price Monitoring Extn
2nd Nov 20202:01 pmRNSPrice Monitoring Extension
29th Oct 20204:40 pmRNSSecond Price Monitoring Extn
29th Oct 20204:35 pmRNSPrice Monitoring Extension
29th Oct 20207:00 amRNSIssue of shares to certain directors and TVR
27th Oct 20202:05 pmRNSSecond Price Monitoring Extn
27th Oct 20202:00 pmRNSPrice Monitoring Extension
23rd Oct 20207:00 amRNSUpdate on Pharm2Farm’s COVID-19 mask project
19th Oct 20202:06 pmRNSSecond Price Monitoring Extn
19th Oct 20202:00 pmRNSPrice Monitoring Extension
19th Oct 202012:42 pmRNSFurther re. Conditional Sale of Pharm2Farm holding
19th Oct 202012:35 pmRNSPublication of Circular and Notice of GM
16th Oct 20207:00 amRNSFurther update re Paraytec Limited
8th Oct 20204:09 pmRNSUpdate on Pharm2Farm
5th Oct 202011:20 amRNSFurther update re Paraytec Limited
29th Sep 20204:40 pmRNSSecond Price Monitoring Extn
29th Sep 20204:35 pmRNSPrice Monitoring Extension
24th Sep 20207:00 amRNSUpdate on Phasefocus Holdings Limited
18th Sep 20207:00 amRNSUpdate on the Pharm2Farm anti-viral mask project
8th Sep 202012:18 pmRNSResult of AGM
3rd Sep 20207:00 amRNSFurther re Paraytec Limited
28th Aug 20205:00 pmRNSTotal Voting Rights
21st Aug 20205:09 pmRNSConditional Sale of Pharm 2 Farm Limited holding
20th Aug 20201:04 pmRNSHolding(s) in Company
5th Aug 20204:41 pmRNSSecond Price Monitoring Extn
5th Aug 20204:35 pmRNSPrice Monitoring Extension
5th Aug 20207:00 amRNSFurther re Paraytec Limited
4th Aug 20207:00 amRNSFinal Results
23rd Jul 202011:00 amRNSPrice Monitoring Extension
21st Jul 20204:41 pmRNSSecond Price Monitoring Extn
21st Jul 20204:36 pmRNSPrice Monitoring Extension
13th Jul 20207:18 amRNSParticipation in RMS placing
7th Jul 20207:00 amRNSFurther re Paraytec Limited
1st Jul 20202:31 pmRNSHolding(s) in Company
30th Jun 20205:00 pmRNSTotal Voting Rights
30th Jun 20203:00 pmRNSAcquisition of 18.1% interest in RMS
19th Jun 20202:29 pmRNSOperational Update
9th Jun 20207:00 amRNSFurther re Paraytec Limited
8th Jun 20207:00 amRNSHolding(s) in Company
5th Jun 202012:44 pmRNSDirector/PDMR Shareholding
5th Jun 20207:00 amRNSAcquisition of Additional PhaseFocus Shares
3rd Jun 20209:05 amRNSSecond Price Monitoring Extn
3rd Jun 20209:00 amRNSPrice Monitoring Extension
3rd Jun 20207:00 amRNSDirector/PDMR Shareholding
2nd Jun 20204:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.